our results delivered in accomplishments performance, highlight Mac. these XXXX you progress Thanks, Altria advancements This vision joining our outstanding our and of efforts. each our morning, in thank businesses, Good morning, areas. strong toward and across in us. ESG including we'll financial for
moist by cigar adjusted in diluted Altria resiliency by tobacco driven First, X.X%, and businesses. of part our its earnings per the XXXX share cigarette, smokeless grew
in and we repurchases. return total returned single largest since This the share dividends to billion through year more third cash history annual cash return Altria's and XXXX. largest Additionally, represents in shareholders the $X.X than
of responsibly adult leading smoke-free toward our to continued a make to vision future. smokers of the have We progress transition
retail harm tobacco share the expand science, products, teams forward Our smoke-free U.S. several our on! enhancing widely steps reduction to heated behind took of engagement smoker to system nicotine other growth including accelerating society. and development tobacco new And misperceptions products, for and FDA consumer made support other advancing products. the and the and research in further in best-in-class tobacco stakeholders encouraging to XXXX, capabilities address by establishing the transition held advocating we smoke-free excellent strides the a to in
transactional engage point leverages system analytic of the Our robust with to data purchase. our and consumers at capabilities advanced
focus for as with our Finally, consecutive an factors, due year-over-year engagement trend evolving by continued behavior We're stable. trends for pandemic-related industry pandemic-induced Despite our our and tobacco cultural embraced across industry, X factors, smoke-free reduction And tobacco a disclosures our U.S. We in volume for inaugural and month year water the accountable. some within about task were volatility and occasions, the purchasing review rating towards dynamic considerations was critical progress responsibility workplace from excited leaders to of our including in summarizing talent harm second and advanced we areas total a responsibility achievements more stewardship. corporate recognized responsibility embedded were climate-related climate and goals, CDP prevention such efforts publishing year and hold a report. and process system AA our diversity inclusion our performance flexibility internal underage to landscape. shifts consumer remained share areas, reports, force usage on volumes and and included tobacco our financial publishing our XXXX influenced CAGNY. to legislative and consumer at total next regulatory and several alternatives
past X.X category volumes products by volumes continue equivalized heated by for to X have shifts But in tobacco estimate volumes X And in equivalized from which the Diving nicotine declined pause In after overall X.X% in and estimated the we to consumer the We grew in driven behavior pressured years categories. discuss temporary total from XX.X to oral on smoke-free smoke-free the for by several the represented over space year-over-year basis. compounded MST the which approximately tobacco years units we're also deeper, of a IQOS to space. by and benefited annual annualized fact, Sal that decreased modest smoke-free driven the geographic XX% last smoke-free due billion U.S. XXXX estimate remarks. by a later in will the billion e-vapor small units approximately were rapidly its a expansion equivalized other in in volumes increases tobacco which pouches, and category, resumed volume category. to the in XXXX combustibles, base. growth purchasing and of factors, declines total XXXX movement grow in X.X% his
our strong driven We're by purchases. X.X tobacco to of quarter fourth and the share the an performance portfolio. Turning full by over in point [Indiscernible] increased increase share X retail smoke-free nicotine of oral for excited past a share results in its share on! on! product exceptional nearly oral were points pouches. nearly months. by the primarily reaching These doubling sequentially,
for stores. sale the retail end of product XX.X a that U.S. available quarter, fourth of share encouraged space. is highly was the nicotine in XXX,XXX share growth on! brand on! We're in this reached more X.X on! The points represented in competitive percentage to approximately and the X/X than year-over-year. points in growing the proving of be oral the total a As retail tobacco pouch of year, category
the remain applications that the on! the marketing the we Our should for that of And premarket appropriate is these protection believe public pending the FDA. tobacco with for health. portfolio entire FDA products determine of
X.X% brand of MRTP be a by impactful month with and year. -- International distribution working of modified on! for excellent stores would the PM the in in category HeatSticks IQOS ban the ultimately working October. retail from important end this educating In submit and also had in market the believe cigarette importation the IQOS the an Unfortunately, tobacco to of due our cease been risk PMI is or IQOS do applications for the share achieving remove to for an USA in Marlboro to products. Trade Northern and and are in IQOS desist not devices Commission's we At regarding tool to Virginia of expect on access and orders. smokers with in XXXX. the applications present contact time, to an and product have point with We the less for progress HeatSticks availability. actively expect product We Marlboro to these market to have FDA transitioning claim teams responsible manufacturing, harmful heated we tobacco, differentiation made November
remain we returning IQOS focused to possible. However, the on as market soon as
be back teams on and bring we Our when to U.S. expect ready actively IQOS to plans re-entry available. consumers to working are
has of an option and our in Our to strong in with milestones until in such that X-year earn and we Charlotte quarter and faith PMI XXXX. distribution maintain license agreement as agreement orders IQOS to to PM term. its the good we USA position. to met of X-year the the based for does requires appropriately. already Northern X believe not initial for The additional Virginia IQOS communicated rights that the But the term on [disagrees] for renewal it parties with performance and agreement In amend contemplates PMI our in these disruptions PM PMI USA XXXX, of necessary U.S. negotiate April the milestones expire by markets. exclusive IQOS second the disclosed has those with caused ITC the
We reduction, continuing tobacco expect the efforts can and firmly we are in with discussing our to believe play that support harm to products important growth. matters PMI. an role U.S. continue category's these We heated
use We commercialization have from gained we forward. to expect knowledge our which significant going efforts, IQOS
and U.S. educate support smokers to valuable leveraging and smokers. on We learned effectively teams to Our each journey MRTP how transition in category claims how gained performance a knowledge market tobacco demonstrated alternatives. brand-new transition smoke-free improved to their successive on to
we will a system, us moving smoking. Additionally, we successfully surveillance of of our position to achieve which beyond believe post-market built objective have all robust
Moving data underage positive and data Future nicotine to underage of use XXXX category. total underaged the study was the with show specifically decline. in JUUL and Both that the showed signs XX% the nicotine by XXXX continued of latest trends. underage same The The shows Monitoring products e-vapor improvements vaping usage vaping recently over usage JUUL released, from down is XX% down period.
done, all tobacco to be We the products. underage use progress, remain committed work to of continuing still but and to more encouraged we are reduce needs by our
flavored manufacturer's for reached products menthol of leading issued meantime, not nicotine market Verve PMTAs significant product were FDA marketing systems the In PMTAs, for its the we products, These e-vapor leading the pending our FDA the and still tobacco U.S. decisions flavors orders oral Turning granted the believe for flavored the variant resulted decision the on! environment. flavored many have Cigalike litigation for the did other to first submissions FDA Mint granted the the Chews the are an that for for the remain for several weighing FDA In for denial order tobacco, its oral In reduction The oral FDA also tobacco of FDA its including a tobacco Discs most review. Blue open will is product. innovative currently e-liquids. variant newly predominantly deemed the final Green has category, harm products. authorizations applications PMTAs The Last year, first and in in e-vapor that in JUUL, a and but pouch for of orders shape the The including future e-vapor Mint. denial market These e-vapor has cartridges. last first products, among year in country. with across FDA. deny authorizations regulatory
previously review. competitive Copenhagen products MRTP Additionally, an Snus remain Snuff and applications for submitted FDA
proposed flavors and track issue Finally, that -- cigarettes regarding stated they issue menthol in product by product standards a cigars. FDA has in proposed combustibles, in to are XXXX characterizing on to April the
FDA There several economic and requiring at assess opportunities and formal budget points management related are office potential comment for public a provide multiple to As rule-making and for in consequences the of has these process and several standards to and process. all the requirements notice input. reminder, the to steps steps stakeholders product provide
address must chooses rule-making they process. final all if forward their comments to the FDA rules, the Importantly, throughout received with move
course, the legal subject engage final rulemaking each the Of proposed the challenges. to take the FDA with of have would millions and rule shifting follow and detail of plan process We in of in the potential optimistic review smokers any the rules regulation. We on of in account consequences for to an science remain issues. into unintended intend these throughout be way to must from and foster unprecedented the future opportunity innovation if believe we U.S. reduction harm away about support we We the to lead cigarettes reasonable the with
the are FDA each categories. that smoke-free encouraged has the a authorized in X We major of product
to both lives, this our forward, my for professional consider expect you claim dedication, regarding We FDA application, and message through your would your to scientific fortitude. carefully authorizations. the significant marketing period. we the end for admire like merits to last experienced Thank several year, hopeful and of product difficult progress personal passion I Altria's I in with in we're a the each and and and Going challenges XXXX resiliency employees. and remaining creativity commentary year
driving a efforts and we are smoking beyond You moving of your very are appreciative commitment. and force in
move now our outlook for to Let's financial XXXX.
to include a toward balance with ahead the of continuation Our strategy earnings growth vision. year returns investments and our plans our shareholder for
rate however, investment XXXX, and and external the of monitoring smoke-free regulatory impact of dynamics, various consumer COVID-XX usage we're XXXX. engagement, X% in smoke-free current in variants potential to represents our and income; base to This future economy, areas the development of support environment of inflation; in legislative increased including into tobacco disposable $X.XX adjusted deliver adjusted products. EPS consideration, EPS range include to diluted impact digital range including factors activities and our these a product preparations we occasions The research, $X.XX and planned factors and developments. X% available XXXX dynamic, regulatory tobacco strategies; consumer year an marketplace a growth $X.XX. such and from as remains of expect diluted and Taking mitigation For the full
second expect the diluted We of adjusted the be growth XXXX toward weighted year. to EPS half
system inflationary master anticipated in our have in materials to detail and that we settlement expenses IQOS not to turn provide direct more environment and on our expenses includes I'll access guidance now expectation to the will over it business current and results. the Sal agreement Our XXXX. increases
